Using Autobioluminescent Cells To Reduce The Cost And Complexity Of Optical Imaging
Autobioluminescent cells utilize a genetically engineered synthetic luciferase system to continuously emit bioluminescent signals without needing external stimulation. These cells produce both a luciferase enzyme and a synthetic pathway that converts natural intracellular molecules into the luciferin substrate, enabling them to autonomously generate light. This self-regulating bioluminescence reflects the cells’ metabolic activity and can respond to various intra- or extracellular signals.
Unlike traditional firefly luciferase reporters, which require costly and repetitive addition of chemical substrates, autobioluminescent cells simplify imaging workflows by eliminating this step. This not only reduces costs but also increases data collection efficiency per experiment. The technology allows for non-destructive, hands-free monitoring using standard optical imaging equipment, enabling continuous and dynamic bioluminescent screening.
Explore how autobioluminescent cells enhance current bioluminescent imaging techniques and introduce novel applications that take advantage of their autonomous light production to obtain new insights unavailable with traditional reporter systems.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.